OSCC tumor cells can actively synthesize sclerostin in vitro, and their cellular properties in terms of proliferation, migration, and invasion can be enhanced by sclerostin treatment, which appears to be dose- and time-dependent, with these effects most evident at higher doses of sclerostin and longer treatment times. Here, SOST is linked to neoplasm.